Silence Therapeutics (SLN) Retained Earnings (2019 - 2025)
Historic Retained Earnings for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to -$550.8 million.
- Silence Therapeutics' Retained Earnings fell 2229.18% to -$550.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$550.8 million, marking a year-over-year decrease of 2229.18%. This contributed to the annual value of -$474.0 million for FY2024, which is 975.93% down from last year.
- Per Silence Therapeutics' latest filing, its Retained Earnings stood at -$550.8 million for Q3 2025, which was down 2229.18% from -$529.8 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Retained Earnings registered a high of -$284.7 million during Q2 2021, and its lowest value of -$550.8 million during Q3 2025.
- For the 5-year period, Silence Therapeutics' Retained Earnings averaged around -$379.3 million, with its median value being -$361.0 million (2023).
- As far as peak fluctuations go, Silence Therapeutics' Retained Earnings plummeted by 4073.64% in 2021, and later increased by 6.08% in 2022.
- Over the past 5 years, Silence Therapeutics' Retained Earnings (Quarter) stood at -$300.6 million in 2021, then fell by 2.74% to -$308.8 million in 2022, then decreased by 22.44% to -$378.1 million in 2023, then dropped by 25.39% to -$474.0 million in 2024, then decreased by 16.19% to -$550.8 million in 2025.
- Its Retained Earnings stands at -$550.8 million for Q3 2025, versus -$529.8 million for Q2 2025 and -$502.5 million for Q1 2025.